Spero Therapeutics Inc.

AI Score

0

Unlock

0.97
0.02 (2.21%)
At close: Jan 14, 2025, 3:59 PM
0.99
2.55%
After-hours Jan 14, 2025, 06:25 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue 96.73M 48.58M 18.26M 9.33M 4.74M 3.97M 1.98M 335.00K n/a
Cost of Revenue 367.00K 1.55M 1.12M 67.00M 65.78M 33.88M 32.87M 26.33M 11.00K
Gross Profit 96.37M 47.03M 17.14M -57.67M -61.03M -29.92M -30.89M -26.00M -11.00K
Operating Income 21.48M -42.20M -87.97M -79.11M -63.22M -42.81M -41.73M -33.22M -13.33M
Interest Income 3.94M 1.11M 346.00K 401.00K 1.33M 1.14M 303.00K n/a n/a
Pretax Income 25.40M -46.41M -89.76M -78.28M -60.92M -41.66M -46.10M -32.64M -13.15M
Net Income 22.81M -48.03M -91.30M -77.52M -60.17M -41.66M -46.10M -25.49M -10.15M
Selling & General & Admin 25.55M 36.48M 41.70M 21.44M 15.59M 12.89M 10.84M 7.22M 2.20M
Research & Development 51.44M 47.59M 64.53M 67.00M 65.78M 33.88M 32.87M 26.33M 11.13M
Other Expenses -1.74M -4.93M -395.00K 833.00K -13.40M 1.14M -4.37M n/a 174.00K
Operating Expenses 75.25M 79.15M 106.23M 88.44M 67.96M 42.81M 41.73M 33.56M 13.33M
Interest Expense n/a 2.60M 1.94M n/a n/a 303.00K 303.00K n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 75.25M 79.15M 106.23M 88.44M 67.96M 42.81M 41.73M 33.56M 13.33M
Income Tax 2.60M 1.61M 1.54M -761.00K -750.00K 1.14M -363.00K -7.73M -3.17M
Shares Outstanding (Basic) 52.70M 37.59M 30.90M 22.39M 18.16M 16.00M 2.59M 6.60M 6.60M
Shares Outstanding (Diluted) 52.99M 37.59M 30.90M 22.39M 18.16M 16.00M 2.59M 6.60M 6.60M
EPS (Basic) 0.43 -1.28 -2.96 -3.46 -3.31 -2.6 -17.82 -3.86 -1.54
EPS (Diluted) 0.43 -1.28 -2.96 -3.46 -3.31 -2.6 -17.82 -3.86 -1.54
EBITDA 25.77M -42.26M -87.17M -76.93M -62.47M -42.40M -41.37M -32.94M -13.32M
Depreciation & Amortization 367.00K 1.55M 1.12M 1.35M 1.16M 409.00K 363.00K 279.00K 11.00K